Mesoblast (MEOBF) Other Working Capital Changes (2014 - 2025)
Mesoblast's (MEOBF) quarterly Other Working Capital Changes came in at -$865000.0 in Q2 2023, down 101.63% year-over-year from $53.0 million in Q2 2022, and down 26.83% quarter-over-quarter from -$682000.0 in Q1 2023.
Analysis
Mesoblast (MEOBF) Other Working Capital Changes (2014 - 2025) Analysis & Trends
Mesoblast has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$3.0 million for Q2 2025.
- In Q2 2023, Other Working Capital Changes fell 101.63% year-over-year to -$865000.0; the TTM figure through Jun 2023 stood at -$3.1 million (down 11.94% YoY), while the FY2026 annual figure was -$2.3 million, down 18.91% from the prior year.
- Other Working Capital Changes came in at -$865000.0 for Q2 2023 at Mesoblast, down from -$682000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$335000.0 in Q3 2019 to a low of -$1.2 million in Q1 2020.
- Average Other Working Capital Changes over 5 years is -$731923.1, with a median of -$695000.0 recorded in 2019.
- Year-over-year, Other Working Capital Changes tumbled 107.46% in 2020 and surged 49.14% in 2021.
- Over 5 years, Other Working Capital Changes stood at -$695000.0 in 2019, then slipped by 12.95% to -$785000.0 in 2020, then jumped by 32.74% to -$528000.0 in 2021, then gained by 18.75% to -$429000.0 in 2022, then plunged by 101.63% to -$865000.0 in 2023.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$865000.0 in Q2 2023, -$682000.0 in Q1 2023, and -$429000.0 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Sep 30, 2019 | -164,000.00 |
| Sep 30, 2019 | -164,000.00 |
| Sep 30, 2018 | -251,000.00 |
| Sep 30, 2018 | -251,000.00 |
| Sep 30, 2017 | 1.33 Mn |
| Sep 30, 2017 | 1.33 Mn |
| Sep 30, 2015 | -227,000.00 |
| Sep 30, 2015 | -227,000.00 |
| Sep 30, 2014 | -641,000.00 |
| Sep 30, 2014 | -641,000.00 |